- Takeda Pharmaceutical participated in 4 rounds in the past year.
- The total disclosed amount of capital deployed in those rounds was $141,000,000 (averaging $35,250,000 per round).
- Molecular Templates: Post-IPO equity ($60M)
- PvP Biologics: Venture capital ($35M)
- Avidity NanoMedicines: Venture capital (Series B) ($10M)
Want to see the complete list?